What is Minus-Eleven?
Established in 1970, Minus-Eleven has cultivated a deep-moat business model centered on the design, installation, and maintenance of high-performance environmental rooms. By catering specifically to the rigorous standards of the life sciences and pharmaceutical sectors, the company serves as a foundational partner for research and manufacturing facilities. Their expertise in navigating complex regulatory environments and technical specifications has allowed them to maintain a dominant footprint in a niche market that demands absolute reliability and long-term service continuity.
How much funding has Minus-Eleven raised?
Minus-Eleven has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Minus-Eleven
PPP
Public-Private Partnership
What's next for Minus-Eleven?
With this late-stage funding, Minus-Eleven is positioned to accelerate its strategic initiatives, likely focusing on the modernization of its service infrastructure and the expansion of its technical footprint. As the pharmaceutical industry continues to invest heavily in domestic manufacturing and advanced research capabilities, the demand for sophisticated, compliant environmental storage solutions is expected to rise. The company will likely leverage this capital to enhance its service delivery models, potentially integrating advanced monitoring technologies to provide predictive maintenance, thereby solidifying its competitive advantage against emerging market entrants.
See full Minus-Eleven company page
